STAT

Opinion: Male doctors said my ‘female’ cancer was incurable. Then a woman took command and gave me hope

My daughter asked me, "Would you ever again let a male doctor treat you for a woman's illness?" I'm not sure.

When my silent assassin emerged last autumn, I pressed my surgeon about the prognosis for a form of peritoneal cancer that strikes women in stealthy fashion.

“Do you really want to know?” he replied. “Your cancer is incurable.” As I gazed at him in disbelief, he coolly recommended palliative care at a nearby regional hospital with an easy commute. My memory of this moment has a Caravaggio-like quality, a camera obscura scene of shadows and shock. I did not weep. I rebelled. I raged at the notion of being ushered toward a comfortable death by male doctors from a community hospital who confidently assured me that this was the sole treatment for a female malady.

I had ignored the symptoms for long enough that it appeared to my physicians to be too late for aggressive action. Last November, on a Thanksgiving journey to New York,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks